Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Adourian Aram S. | VP, Scientific Affairs | 14 | $0 | $0 | 2016-03-31 |
| SOHMER PAUL R | President & CEO | 6 | $0 | $0 | 2016-03-31 |
| HALL STEPHEN P | EVP & Chief Financial Officer | 6 | $0 | $0 | 2016-03-31 |
| LUBER JEFFREY R | Director | 1 | $0 | $0 | 2016-02-04 |
| AFEYAN NOUBAR | Director, 10% Owner | 36 | $0 | $26.6K | 2015-12-09 |
| PAPADOPOULOS STELIOS | Director | 6 | $500.0K | $0 | 2015-11-18 |
| OCONNOR JAMES F O | Director | 1 | $0 | $0 | 2015-11-18 |
| WILCOX HARRY W | Director | 1 | $0 | $0 | 2015-11-18 |
| Flagship Ventures Management, Inc. | 10% Owner | 50 | $0 | $1.4K | 2015-07-27 |
| Applied Genomic Technology Capital Fund LP | 10% Owner | 18 | $0 | $11.3K | 2015-07-27 |
| NewcoGen Group, Inc. | 10% Owner | 29 | $90.9K | $1.1K | 2015-07-14 |
| KANIA EDWIN M JR | 10% Owner | 22 | $0 | $201.4K | 2014-12-11 |
| Bancel Stephane | Executive Chairman | 10 | $169.6K | $0 | 2014-06-03 |
| Harris Timothy J.R. | Director | 4 | $0 | $0 | 2014-06-03 |
| Posner Brian S | Director | 5 | $52.1K | $0 | 2014-06-03 |
| BAINS HARRISON M JR | Director | 4 | $0 | $0 | 2014-06-03 |
| Rader Anastasia | SVP, Executive Operations & HR | 4 | $0 | $0 | 2014-02-04 |
| AGTC Partners, L.P. | 10% Owner | 5 | $4.00M | $0 | 2013-01-30 |
| Abdalian Charles H Jr | EVP & Chief Financial Officer | 1 | $0 | $0 | 2012-12-10 |
| Densel William | General Manager, CardioSCORE | 1 | $0 | $0 | 2012-08-08 |
| Muntendam Pieter | EVP, Chief Medical Officer | 4 | $0 | $186.1K | 2012-06-08 |
| Bouvier Eric | President, CEO | 2 | $39.5K | $0 | 2012-05-23 |
| van der Meer Pieter | 10% Owner | 1 | $0 | $1.32M | 2012-04-17 |
| Miller Stephen R. | Chief Commercial Officer | 1 | $0 | $0 | 2012-02-22 |
| ROGERS MICHAEL W | EVP, CFO and Treasurer | 1 | $0 | $0 | 2012-02-22 |
| GORDON NEAL | SVP, Biomarker Discovery | 1 | $0 | $0 | 2012-02-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Adourian Aram S. | SVP & Chief Scientific Offic | F Tax w/h | 2016-03-31 | 2016-04-04 | 7,456 | $0.36 | $2.7K | 35,770 | SEC↗ |
| HALL STEPHEN P | EVP & Chief Financial Office | F Tax w/h | 2016-03-31 | 2016-04-04 | 8,986 | $0.36 | $3.2K | 31,034 | SEC↗ |
| SOHMER PAUL R | President & CEO | F Tax w/h | 2016-03-31 | 2016-04-04 | 15,493 | $0.36 | $5.6K | 53,161 | SEC↗ |
| LUBER JEFFREY R | Director | A Award deriv | 2016-02-04 | 2016-02-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2015-12-09 | 2015-12-11 | 43,930 | $0.56 | $24.6K | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2015-12-09 | 2015-12-11 | 2,508 | $0.56 | $1.4K | 0 | SEC↗ |
| OCONNOR JAMES F O | Director | A Award deriv | 2015-11-18 | 2015-11-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2015-11-18 | 2015-11-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PAPADOPOULOS STELIOS | Director | A Award deriv | 2015-11-18 | 2015-11-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| WILCOX HARRY W | Director | A Award deriv | 2015-11-18 | 2015-11-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | F Tax w/h | 2015-08-15 | 2016-04-04 | 6,233 | $0.83 | $5.2K | 43,226 | SEC↗ |
| HALL STEPHEN P | EVP & Chief Financial Office | F Tax w/h | 2015-08-15 | 2016-04-04 | 7,530 | $0.83 | $6.2K | 40,020 | SEC↗ |
| SOHMER PAUL R | President & CEO | F Tax w/h | 2015-08-15 | 2015-08-19 | 13,321 | $0.83 | $11.1K | 68,654 | SEC↗ |
| HALL STEPHEN P | EVP & Chief Financial Office | F Tax w/h | 2015-08-15 | 2015-08-19 | 7,505 | $0.83 | $6.2K | 39,995 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | F Tax w/h | 2015-08-15 | 2015-08-19 | 6,233 | $0.83 | $5.2K | 40,226 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 53,857 | — | $0 | 0 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 4,205 | — | $0 | 0 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 4,205 | — | $0 | 0 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 4,205 | — | $0 | 0 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 4,205 | — | $0 | 0 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 8,410 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 3,256 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 254 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 254 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 254 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 508 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2015-07-27 | 2015-07-29 | 254 | — | $0 | 0 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 4,205 | $0.14 | $589 | 775,415 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 53,857 | $0.14 | $7.5K | 766,720 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 530 | $2.27 | $1.2K | 786,970 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 8,410 | $0.14 | $1.2K | 787,500 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 265 | $2.27 | $602 | 779,090 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 4,205 | $0.14 | $589 | 779,355 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 265 | $2.27 | $602 | 775,150 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 265 | $2.27 | $602 | 771,210 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 4,205 | $0.14 | $589 | 771,475 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 265 | $2.27 | $602 | 767,270 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 4,205 | $0.14 | $589 | 767,535 | SEC↗ |
| Applied Genomic Technology Cap | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 3,390 | $2.27 | $7.7K | 763,330 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 16 | $2.27 | $36 | 57,280 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 254 | $0.14 | $36 | 57,296 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 16 | $2.27 | $36 | 57,042 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 254 | $0.14 | $36 | 57,534 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 16 | $2.27 | $36 | 57,518 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 254 | $0.14 | $36 | 57,772 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 16 | $2.27 | $36 | 57,756 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 508 | $0.14 | $71 | 58,264 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 32 | $2.27 | $73 | 58,232 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 254 | $0.14 | $36 | 57,058 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2015-07-27 | 2015-07-29 | 206 | $2.27 | $468 | 56,804 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2015-07-27 | 2015-07-29 | 3,256 | $0.14 | $456 | 57,010 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | C Conversion deriv | 2015-07-14 | 2015-07-16 | 13,553 | — | $0 | 13,553 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | C Conversion deriv | 2015-07-14 | 2015-07-16 | 725,725 | — | $0 | 909,696 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | J Other deriv | 2015-07-14 | 2015-07-16 | 183,971 | — | $0 | 183,971 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | C Conversion deriv | 2015-07-14 | 2015-07-16 | 397,072 | — | $0 | 497,729 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | J Other deriv | 2015-07-14 | 2015-07-16 | 100,657 | — | $0 | 100,657 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | P Buy deriv | 2015-07-14 | 2015-07-16 | 0 | $1.70 | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | J Other deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | C Conversion deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | C Conversion deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | P Buy deriv | 2015-07-14 | 2015-07-16 | 0 | $1.70 | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | P Buy deriv | 2015-07-14 | 2015-07-16 | 53,465 | $1.70 | $90.9K | 67,018 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | C Conversion deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | A Award deriv | 2015-02-20 | 2015-02-24 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SOHMER PAUL R | President & CEO | A Award deriv | 2015-02-20 | 2015-02-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| HALL STEPHEN P | EVP & Chief Financial Office | A Award deriv | 2015-02-20 | 2015-02-24 | 140,000 | — | $0 | 140,000 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-11 | 2014-12-11 | 369,112 | $0.30 | $110.7K | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-11 | 2014-12-11 | 18,468 | $0.30 | $5.5K | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-10 | 2014-12-11 | 5,472 | $0.32 | $1.8K | 18,468 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-10 | 2014-12-11 | 109,248 | $0.32 | $35.0K | 369,112 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-09 | 2014-12-11 | 125,789 | $0.36 | $45.3K | 478,360 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-09 | 2014-12-11 | 6,301 | $0.36 | $2.3K | 23,940 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 98,352 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 98,570 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 11,190 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 703,655 | — | $0 | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 164,528 | — | $0 | 175,718 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 2,484,192 | — | $0 | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 10,029 | — | $0 | 10,029 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 11,190 | — | $0 | 11,190 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 592,959 | — | $0 | 604,149 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 593 | — | $0 | 593 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | J Other | 2014-12-04 | 2014-12-05 | 29,648 | — | $0 | 30,241 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 1,724 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 1,724 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 1,724 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 464 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 847 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 850 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 499 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 1,729 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 1,729 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 1,729 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 12,183 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 12,183 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 12,183 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 5,988 | — | $0 | 0 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 12,021 | — | $0 | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 17,080 | — | $0 | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 17,080 | — | $0 | 0 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | X Exercise deriv | 2014-12-03 | 2014-12-05 | 17,080 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 464 | $0.04 | $19 | 92,590 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 37 | $0.46 | $17 | 92,553 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 847 | $0.02 | $17 | 93,400 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 31 | $0.46 | $14 | 93,369 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 1,724 | $0.02 | $34 | 95,093 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 63 | $0.46 | $29 | 95,030 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 63 | $0.46 | $29 | 98,352 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 1,724 | $0.02 | $34 | 98,415 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 63 | $0.46 | $29 | 96,691 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 1,724 | $0.02 | $34 | 96,754 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 32 | $0.46 | $15 | 93,572 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 850 | $0.02 | $17 | 93,604 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 39 | $0.46 | $18 | 92,754 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 499 | $0.04 | $20 | 92,793 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 63 | $0.46 | $29 | 98,570 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 1,729 | $0.02 | $35 | 98,633 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 63 | $0.46 | $29 | 96,904 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 1,729 | $0.02 | $35 | 96,967 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 63 | $0.46 | $29 | 95,238 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 1,729 | $0.02 | $35 | 95,301 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 927 | $0.46 | $426 | 662,654 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 12,021 | $0.04 | $481 | 663,581 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 5,988 | $0.02 | $120 | 668,642 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 440 | $0.46 | $202 | 703,655 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 12,183 | $0.02 | $244 | 704,095 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 440 | $0.46 | $202 | 691,912 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 12,183 | $0.02 | $244 | 692,352 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 440 | $0.46 | $202 | 680,169 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 12,183 | $0.02 | $244 | 680,609 | SEC↗ |
| NewcoGen Group, Inc. | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 216 | $0.46 | $99 | 668,426 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 17,080 | $0.02 | $342 | 2,484,808 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 616 | $0.46 | $283 | 2,484,192 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 616 | $0.46 | $283 | 2,467,728 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 17,080 | $0.02 | $342 | 2,468,344 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | S Sale | 2014-12-03 | 2014-12-05 | 616 | $0.46 | $283 | 2,451,264 | SEC↗ |
| KANIA EDWIN M JR | 10% Owner | X Exercise | 2014-12-03 | 2014-12-05 | 17,080 | $0.02 | $342 | 2,451,880 | SEC↗ |
| SOHMER PAUL R | President & CEO | A Award | 2014-10-16 | 2014-10-17 | 327,900 | — | $0 | 327,900 | SEC↗ |
| HALL STEPHEN P | EVP & Chief Financial Office | A Award | 2014-10-16 | 2014-10-17 | 190,200 | — | $0 | 190,200 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | A Award | 2014-10-16 | 2014-10-17 | 157,800 | — | $0 | 185,836 | SEC↗ |
| Bancel Stephane | Director | A Award deriv | 2014-06-03 | 2014-06-05 | 4,205 | — | $0 | 4,205 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2014-06-03 | 2014-06-05 | 4,205 | — | $0 | 4,205 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2014-06-03 | 2014-06-05 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Harris Timothy J.R. | Director | A Award deriv | 2014-06-03 | 2014-06-05 | 4,205 | — | $0 | 4,205 | SEC↗ |
| PAPADOPOULOS STELIOS | Director | A Award deriv | 2014-06-03 | 2014-06-05 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2014-06-03 | 2014-06-05 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | M Exercise deriv | 2014-04-14 | 2016-05-04 | 12,000 | — | $0 | 16,036 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | M Exercise | 2014-04-14 | 2016-05-04 | 12,000 | $0.90 | $10.8K | 40,036 | SEC↗ |
| SOHMER PAUL R | President & CEO | A Award deriv | 2014-02-04 | 2014-02-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | A Award deriv | 2014-02-04 | 2014-02-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | A Award deriv | 2014-02-04 | 2014-02-06 | 93,000 | — | $0 | 93,000 | SEC↗ |
| Rader Anastasia | SVP, Executive Operations & | A Award deriv | 2014-02-04 | 2014-02-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rader Anastasia | SVP, Executive Operations & | A Award deriv | 2014-02-04 | 2014-02-06 | 42,000 | — | $0 | 42,000 | SEC↗ |
| HALL STEPHEN P | EVP & Chief Financial Office | A Award deriv | 2013-12-17 | 2013-12-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Bancel Stephane | Director | A Award deriv | 2013-11-01 | 2013-11-04 | 101,351 | — | $0 | 101,351 | SEC↗ |
| Bancel Stephane | Director | A Award deriv | 2013-08-01 | 2013-08-05 | 52,083 | — | $0 | 52,083 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2013-06-12 | 2013-06-14 | 4,205 | — | $0 | 4,205 | SEC↗ |
| PAPADOPOULOS STELIOS | Director | A Award deriv | 2013-06-12 | 2013-06-14 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Harris Timothy J.R. | Director | A Award deriv | 2013-06-12 | 2013-06-14 | 4,205 | — | $0 | 4,205 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2013-06-12 | 2013-06-14 | 4,205 | — | $0 | 4,205 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2013-06-12 | 2013-06-14 | 4,205 | — | $0 | 4,205 | SEC↗ |
| SOHMER PAUL R | President & CEO | A Award deriv | 2013-05-10 | 2013-05-14 | 700,000 | — | $0 | 700,000 | SEC↗ |
| Bancel Stephane | Executive Chairman | A Award deriv | 2013-05-01 | 2013-05-03 | 39,473 | — | $0 | 39,473 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | A Award deriv | 2013-04-26 | 2013-04-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Rader Anastasia | SVP, Executive Operations & | A Award deriv | 2013-04-26 | 2013-04-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PAPADOPOULOS STELIOS | Director | P Buy | 2013-01-30 | 2013-02-01 | 250,000 | $2.00 | $500.0K | 1,187,713 | SEC↗ |
| AGTC Partners, L.P. | 10% Owner | P Buy | 2013-01-30 | 2013-02-01 | 1,050,000 | $2.00 | $2.10M | 1,764,286 | SEC↗ |
| AGTC Partners, L.P. | 10% Owner | P Buy | 2013-01-30 | 2013-02-01 | 75,000 | $2.00 | $150.0K | 215,013 | SEC↗ |
| AGTC Partners, L.P. | 10% Owner | P Buy | 2013-01-30 | 2013-02-01 | 125,000 | $2.00 | $250.0K | 651,560 | SEC↗ |
| AGTC Partners, L.P. | 10% Owner | P Buy | 2013-01-30 | 2013-02-01 | 250,000 | $2.00 | $500.0K | 2,434,800 | SEC↗ |
| AGTC Partners, L.P. | 10% Owner | P Buy | 2013-01-30 | 2013-02-01 | 500,000 | $2.00 | $1.00M | 2,851,447 | SEC↗ |
| Abdalian Charles H Jr | EVP & Chief Financial Office | A Award deriv | 2012-12-10 | 2012-12-12 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Posner Brian S | Director | P Buy | 2012-11-19 | 2012-11-20 | 10,000 | $1.17 | $11.7K | 20,000 | SEC↗ |
| Bancel Stephane | Executive Chairman | P Buy | 2012-11-15 | 2012-11-19 | 100,000 | $1.26 | $126.0K | 123,167 | SEC↗ |
| Adourian Aram S. | SVP & Chief Scientific Offic | A Award deriv | 2012-10-04 | 2012-10-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Bancel Stephane | Executive Chairman | P Buy | 2012-09-13 | 2012-09-17 | 1,381 | $3.70 | $5.1K | 23,167 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | J Other | 2012-08-21 | 2012-08-22 | 298,137 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2012-08-20 | 2012-08-22 | 2,353 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2012-08-20 | 2012-08-22 | 6,422 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2012-08-20 | 2012-08-22 | 6,422 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise deriv | 2012-08-20 | 2012-08-22 | 6,422 | — | $0 | 0 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2012-08-20 | 2012-08-22 | 6,422 | $0.02 | $128 | 298,160 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2012-08-20 | 2012-08-22 | 23 | $5.83 | $134 | 291,738 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2012-08-20 | 2012-08-22 | 6,422 | $0.02 | $128 | 291,761 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2012-08-20 | 2012-08-22 | 6,422 | $0.02 | $128 | 285,362 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2012-08-20 | 2012-08-22 | 13 | $5.83 | $76 | 278,940 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | X Exercise | 2012-08-20 | 2012-08-22 | 2,353 | $0.03 | $71 | 278,953 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2012-08-20 | 2012-08-22 | 23 | $5.83 | $134 | 298,137 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | S Sale | 2012-08-20 | 2012-08-22 | 23 | $5.83 | $134 | 285,339 | SEC↗ |
| Densel William | General Manager, CardioSCORE | A Award deriv | 2012-08-08 | 2012-08-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2012-06-11 | 2012-06-13 | 4,205 | — | $0 | 4,205 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2012-06-11 | 2012-06-13 | 4,205 | — | $0 | 4,205 | SEC↗ |
| PAPADOPOULOS STELIOS | Director | A Award deriv | 2012-06-11 | 2012-06-13 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Harris Timothy J.R. | Director | A Award deriv | 2012-06-11 | 2012-06-13 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Muntendam Pieter | EVP, Chief Medical Officer | S Sale | 2012-06-08 | 2012-06-11 | 3,965 | $5.29 | $21.0K | 78,483 | SEC↗ |
| Muntendam Pieter | EVP, Chief Medical Officer | S Sale | 2012-06-07 | 2012-06-11 | 30,021 | $5.50 | $165.1K | 82,448 | SEC↗ |
| Muntendam Pieter | EVP, Chief Medical Officer | M Exercise deriv | 2012-05-30 | 2012-06-01 | 100,000 | — | $0 | 82,239 | SEC↗ |
| Muntendam Pieter | EVP, Chief Medical Officer | M Exercise | 2012-05-30 | 2012-06-01 | 100,000 | $0.90 | $90.0K | 112,469 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | J Other | 2012-05-23 | 2012-05-23 | 130,867 | — | $0 | 0 | SEC↗ |
| Bouvier Eric | President, CEO | P Buy | 2012-05-23 | 2012-05-24 | 10,000 | $3.95 | $39.5K | 10,000 | SEC↗ |
| Posner Brian S | Director | P Buy | 2012-05-22 | 2012-05-23 | 10,000 | $4.04 | $40.4K | 10,000 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2012-05-21 | 2012-05-23 | 7,001 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2012-05-21 | 2012-05-23 | 7,001 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2012-05-21 | 2012-05-23 | 2,580 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2012-05-21 | 2012-05-23 | 2,497 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise deriv | 2012-05-21 | 2012-05-23 | 7,001 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2012-05-21 | 2012-05-23 | 36 | $3.95 | $142 | 116,937 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2012-05-21 | 2012-05-23 | 36 | $3.95 | $142 | 130,867 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2012-05-21 | 2012-05-23 | 7,001 | $0.02 | $140 | 130,903 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2012-05-21 | 2012-05-23 | 36 | $3.95 | $142 | 123,902 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2012-05-21 | 2012-05-23 | 7,001 | $0.02 | $140 | 123,938 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2012-05-21 | 2012-05-23 | 7,001 | $0.02 | $140 | 116,973 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2012-05-21 | 2012-05-23 | 14 | $3.95 | $55 | 109,972 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2012-05-21 | 2012-05-23 | 2,580 | $0.02 | $52 | 109,986 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | S Sale | 2012-05-21 | 2012-05-23 | 19 | $3.95 | $75 | 107,406 | SEC↗ |
| Flagship Ventures Management, | 10% Owner | X Exercise | 2012-05-21 | 2012-05-23 | 2,497 | $0.03 | $75 | 107,425 | SEC↗ |
| Bancel Stephane | Executive Chairman | P Buy | 2012-05-17 | 2012-05-21 | 5,008 | $3.84 | $19.2K | 21,786 | SEC↗ |
| Bancel Stephane | Executive Chairman | P Buy | 2012-05-17 | 2012-05-23 | 5,008 | $3.84 | $19.2K | 21,786 | SEC↗ |
| van der Meer Pieter | 10% Owner | S Sale | 2012-04-17 | 2012-04-19 | 200,000 | $6.60 | $1.32M | 1,635,432 | SEC↗ |
| Adourian Aram S. | VP, Scientific Affairs | M Exercise deriv | 2012-03-19 | 2012-03-21 | 7,009 | — | $0 | 0 | SEC↗ |
| Adourian Aram S. | VP, Scientific Affairs | M Exercise | 2012-03-19 | 2012-03-21 | 7,009 | $0.90 | $6.3K | 28,036 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2012-02-27 | 2012-02-29 | 4,205 | — | $0 | 4,205 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2012-02-27 | 2012-02-29 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Bancel Stephane | Executive Chairman | A Award deriv | 2012-02-27 | 2012-02-29 | 4,205 | — | $0 | 4,205 | SEC↗ |
| Harris Timothy J.R. | Director | A Award deriv | 2012-02-27 | 2012-02-29 | 4,205 | — | $0 | 4,205 | SEC↗ |
| PAPADOPOULOS STELIOS | Director | A Award deriv | 2012-02-27 | 2012-02-29 | 4,205 | — | $0 | 4,205 | SEC↗ |
| ROGERS MICHAEL W | EVP, CFO and Treasurer | A Award deriv | 2012-02-22 | 2012-02-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Miller Stephen R. | Chief Commercial Officer | A Award deriv | 2012-02-22 | 2012-02-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GORDON NEAL | SVP, Biomarker Discovery | A Award deriv | 2012-02-22 | 2012-02-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Adourian Aram S. | VP, Scientific Affairs | A Award deriv | 2012-02-22 | 2012-02-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rader Anastasia | SVP, Executive Operations & | A Award deriv | 2012-02-22 | 2012-02-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Bancel Stephane | Executive Chairman | P Buy | 2012-02-22 | 2012-02-24 | 2,778 | — | $0 | 16,778 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2012-02-13 | 2012-02-15 | 8,410 | — | $0 | 8,410 | SEC↗ |
| Bouvier Eric | President, CEO | A Award deriv | 2012-01-09 | 2012-01-11 | 725,675 | — | $0 | 725,675 | SEC↗ |